Gm2 Gangliosidoses Stocks List
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IBBQ | B | Invesco Nasdaq Biotechnology ETF | 0.05 | |
IBB | B | iShares Nasdaq Biotechnology Index Fund | 0.03 | |
BIB | C | ProShares Ultra Nasdaq Biotechnology | 0.03 | |
VXF | B | Vanguard Extended Market ETF | 0.0 | |
ISCG | B | iShares Morningstar Small-Cap Growth ETF | 0.0 |
Compare ETFs
Related Industries:
Biotechnology
- Gm2 Gangliosidoses
Gm2 Gangliosidoses is a group of rare, inherited disorders caused by the buildup of a fatty substance called GM2 ganglioside in the body's cells. This buildup can cause a wide range of symptoms, including intellectual disability, seizures, movement problems, and vision and hearing loss. Treatment is supportive and may include physical, occupational, and speech therapy, as well as medications to control seizures.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles